Side-by-side comparison of mechanisms, dosing, interactions, and stacking potential.
| Fasoracetam | Panax Ginseng | |
|---|---|---|
| Category | Nootropics | Nootropics |
| Standard Dose | 20-100 mg 1-3 times daily (sublingual or oral) | 200-400 mg/day of standardized extract (4-7% ginsenosides, typically G115 brand) or 1-2 g/day of dried root |
| Timing | Morning and afternoon. Sublingual administration may provide faster onset and higher bioavailability. With or without food. | Morning on an empty stomach or with food. Avoid evening dosing due to mild stimulatory effects. Acute cognitive effects noted within 1-4 hours of dosing. |
| Cycle Duration | Cycles of 4-8 weeks on, 2-4 weeks off. Limited long-term safety data. | Traditionally cycled 2-3 weeks on, 1-2 weeks off. Long-term continuous use exceeding 3 months is debated. |
| Evidence Level | animal_plus_anecdotal | moderate_human |
Non-classical racetam that modulates all three groups of metabotropic glutamate receptors (mGluR Groups I, II, and III) and upregulates GABA-B receptors — a unique mechanism that distinguishes it from other racetams. Also enhances high-affinity choline uptake (HACU) and stimulates acetylcholine release. Does not significantly affect adrenergic, serotonergic, or dopaminergic receptors. The GABA-B upregulation is particularly notable as it may counteract GABA-B receptor downregulation caused by phenibut or baclofen tolerance.
20-100 mg 1-3 times daily (sublingual or oral)
Morning and afternoon. Sublingual administration may provide faster onset and higher bioavailability. With or without food.
Cycles of 4-8 weeks on, 2-4 weeks off. Limited long-term safety data.
Ginsenosides (primarily Rg1, Rb1, Re) are amphipathic steroidal saponins that modulate multiple neurotransmitter systems: enhancement of cholinergic transmission via increased acetylcholine synthesis and release; activation of PI3K/Akt and CREB/BDNF signaling pathways to promote neurogenesis and synaptic plasticity; attenuation of neuroinflammation through Keap1/Nrf2 signaling and suppression of the NF-kB/NLRP3 inflammasome axis; and regulation of the HPA axis to buffer cortisol response to stress. Protopanaxadiol and protopanaxatriol ginsenosides have opposing modulatory effects on GABA-A receptors.
200-400 mg/day of standardized extract (4-7% ginsenosides, typically G115 brand) or 1-2 g/day of dried root
Morning on an empty stomach or with food. Avoid evening dosing due to mild stimulatory effects. Acute cognitive effects noted within 1-4 hours of dosing.
Traditionally cycled 2-3 weeks on, 1-2 weeks off. Long-term continuous use exceeding 3 months is debated.
Take our free assessment to get personalized recommendations based on your health goals, current stack, and biomarkers.
Get Your Free Protocol →or take the assessment →